Home › Uveal Melanoma › Illinois
Uveal Melanoma clinical trials in Illinois
3 studies for Uveal Melanoma are looking for participants at sites in Illinois.
Cities in Illinois
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- University of Chicago Medical Center, Chicago
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT03686124A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Northwestern Memorial Hospital, Chicago
- University of Chicago Medical Center, Chicago
RecruitingPhase 2/3
All ages · All sexes · Updated Apr 2, 2026 · NCT06581406Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
- University of Chicago Medical Center, Chicago
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 4, 2025 · NCT06121180From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.